Nabi Biopharmaceuticals names new CEO

Jan 22 (Reuters) - Nabi Biopharmaceuticals (NABI.O) said it named Raafat Fahim as president and chief executive officer, succeeding Leslie Hudson, who had served as interim CEO since February 2007. Fahim most recently was the chief operating officer and general manager of the company's Biologics Strategic Business Unit, the drugmaker said in a statement. (Reporting by Sreerupa Mitra in Bangalore; Editing by Pratish Narayanan)